AIRGAIN INC Income Taxes Disclosure
Note 10. Income Taxes
Income Taxes
The components of the pretax loss from operations for the years ended December 31 are as follows (in thousands):
|
|
For the Years Ended December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
U.S. Domestic |
|
$ |
6,425 |
|
|
$ |
8,761 |
|
Foreign |
|
|
(72 |
) |
|
|
79 |
|
Pretax loss from operations |
|
$ |
6,353 |
|
|
$ |
8,840 |
|
The income tax expense (benefit) is as follows (in thousands):
|
|
For the Years Ended December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Current: |
|
|
|
|
|
|
||
U.S. federal |
|
$ |
— |
|
|
$ |
— |
|
State and local |
|
|
24 |
|
|
|
30 |
|
Foreign |
|
|
26 |
|
|
|
(193 |
) |
Total current income tax expense (benefit) |
|
|
50 |
|
|
|
(163 |
) |
Deferred: |
|
|
|
|
|
|
||
U.S. federal |
|
|
9 |
|
|
|
9 |
|
State and local |
|
|
14 |
|
|
|
2 |
|
Total deferred income tax expense |
|
|
23 |
|
|
|
11 |
|
Income tax expense (benefit) |
|
$ |
73 |
|
|
$ |
(152 |
) |
Income taxes paid, net of refunds received, for the year ended December 31, 2025 consists of the following (in thousands):
|
|
For the Year Ended December 31, |
|
|
|
|
2025 |
|
|
Federal |
|
$ |
— |
|
State and local |
|
|
(12 |
) |
Foreign |
|
|
|
|
UK |
|
|
63 |
|
China |
|
|
4 |
|
Total |
|
$ |
55 |
|
For the year ended December 31, 2024, the Company had $17.0 thousand income taxes received, net of income taxes paid.
Tax Rate Reconciliation
Upon adoption of ASU 2023-09, Improvements to Income Tax Disclosures, the reconciliation of taxes at the federal statutory rate to our provision for (benefit from) income taxes for the year ended December 31, 2025 was as follows (in thousands, except for percentages):
|
|
For the Year Ended December 31, |
|
|||||
|
|
2025 |
|
|||||
|
|
Amount |
|
|
Percent |
|
||
Income taxes at statutory rates |
|
$ |
(1,334 |
) |
|
|
21.00 |
% |
State income tax* |
|
|
(8 |
) |
|
|
0.12 |
% |
Foreign tax effects |
|
|
|
|
|
|
||
Other Foreign |
|
|
11 |
|
|
|
-0.17 |
% |
Effect of cross -border tax laws |
|
|
|
|
|
|
||
GILTI |
|
|
14 |
|
|
|
-0.23 |
% |
Tax Credits |
|
|
|
|
|
|
||
R&D credit |
|
|
(300 |
) |
|
|
4.72 |
% |
Changes in valuation allowance |
|
|
1,354 |
|
|
|
-21.31 |
% |
Nontaxable or nondeductible items |
|
|
|
|
|
|
||
Other |
|
|
44 |
|
|
|
-0.69 |
% |
Stock-based Compensation |
|
|
180 |
|
|
|
-2.83 |
% |
Other |
|
|
|
|
|
|
||
Other |
|
|
7 |
|
|
|
-0.10 |
% |
Changes in Unrecognized Tax Benefits |
|
|
105 |
|
|
|
-1.66 |
% |
Income tax expense |
|
$ |
73 |
|
|
|
-1.15 |
% |
* State taxes in California for 2025 made up the majority (greater than 50%) of the tax effect in this category.
The reconciliation of taxes at the federal statutory rate to our provision for (benefit from) income taxes for the year ended December 31, 2024 in accordance with the guidance prior to the adoption of ASU 2023-09 was as follows:
|
|
For the Years Ended December 31, |
|
|
|
|
2024 |
|
|
Income taxes at statutory rates |
|
$ |
(1,856 |
) |
State income tax, net of federal benefit |
|
|
32 |
|
Permanent items |
|
|
106 |
|
Equity based compensation |
|
|
259 |
|
Federal research credits |
|
|
(347 |
) |
Federal return to provision |
|
|
35 |
|
Foreign taxes |
|
|
(194 |
) |
Other |
|
|
98 |
|
Change in federal valuation allowance |
|
|
1,715 |
|
Income tax (benefit) expense |
|
$ |
(152 |
) |
Significant Components of Current and Deferred Taxes
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and deferred tax liabilities as of December 31, 2025 and 2024 are as follows (in thousands):
|
|
As of December 31, |
|
|||||
|
|
2025 |
|
|
2024 |
|
||
Deferred tax assets: |
|
|
|
|
|
|
||
Net operating loss carryforwards |
|
$ |
6,659 |
|
|
$ |
5,094 |
|
Research and AMT credits |
|
|
4,840 |
|
|
|
4,427 |
|
Stock based compensation |
|
|
2,117 |
|
|
|
2,080 |
|
Lease liability |
|
|
1,119 |
|
|
|
954 |
|
Section 174 R&D Capitalization |
|
|
4,811 |
|
|
|
5,527 |
|
Accrued and other |
|
|
783 |
|
|
|
908 |
|
Deferred tax assets |
|
|
20,329 |
|
|
|
18,990 |
|
Less valuation allowance |
|
|
(18,542 |
) |
|
|
(16,696 |
) |
Deferred tax assets, net of allowance |
|
|
1,787 |
|
|
|
2,294 |
|
Deferred tax liabilities: |
|
|
|
|
|
|
||
Fixed assets |
|
|
(410 |
) |
|
|
(411 |
) |
Goodwill |
|
|
(580 |
) |
|
|
(518 |
) |
Right-of-use asset |
|
|
(983 |
) |
|
|
(953 |
) |
Intangible asset |
|
|
— |
|
|
|
(575 |
) |
Deferred tax liabilities |
|
|
(1,973 |
) |
|
|
(2,457 |
) |
Total deferred tax liabilities |
|
$ |
(186 |
) |
|
$ |
(163 |
) |
We have established a valuation allowance against our net deferred tax assets due to the uncertainty surrounding the realization of such assets. The Company periodically evaluates the recoverability of the deferred tax assets. At such time it is determined that it is more likely than not that deferred assets are realizable, the valuation allowance will be reduced. The Company has recorded a valuation allowance of $18.5 million as of December 31, 2025 as it does not believe it is more likely than not that certain deferred tax assets will be realized due to the recent history of both pre-tax book income and losses, the lack of taxable income available in carryback periods or feasible tax-planning strategies, the limited existing taxable temporary differences, and the subjective nature of forecasting future taxable income into the future. The Company increased its valuation allowance by approximately $1.8 million during the year ended December 31, 2025.
As of December 31, 2025 the Company had federal and state net operating loss (NOL) carryforwards of approximately $26.4 million, and $14.0 million, respectively. The federal NOL generated post 2017 of $16.8 million can be carried forward indefinitely and may generally be used to offset up to 80% of future taxable income for each year. The remaining federal and state NOL carryforwards begin to expire in 2029 and 2028, respectively, if unused.
As of December 31, 2025 the Company had federal and state tax credit carryforwards of approximately $3.5 million, and $2.8 million, respectively, after reduction for uncertain tax positions. The federal tax credit carryforwards will begin to expire in 2026, if unused, and the California tax credits can be carried forward indefinitely. The other state tax credit carryforwards will begin to expire in 2032.
The above federal and state carryforwards and tax credit carryforwards may be subject to an annual limitation under section 382 and 383 of the Internal Revenue Code of 1986, as amended (the Code), and similar state provisions if we experience one or more ownership changes which would limit the amount of NOL and tax credit carryforwards that can be utilized to offset future taxable income and tax, respectively. In general, an ownership change as defined by Section 382 and 383 of the Code, results from transactions increasing ownership of certain stockholders or public groups in the stock of the corporation by more than 50 percentage points over a rolling three-year period. The Company has completed an ownership change analysis through December 31, 2024 and incorporated the impact of ownership changes prior to this date by reducing the Company's NOL and tax credit carryforwards that may not be utilized due to the annual limitations associated with those ownership change dates. Our use of federal and state NOL and tax credit carryforwards could be limited further by the provisions of Section 382 of the Code, depending upon the timing and amount of additional equity securities that we have issued or will issue, subsequent to December 31, 2025. State NOL carryforwards may be similarly limited. If a change in ownership were to occur, NOL and tax credit carryforwards could be eliminated or restricted. If eliminated, the related asset would be removed from the deferred tax asset schedule with a corresponding reduction in the valuation allowance. Due to the existence of the valuation allowance, limitations created by ownership changes, if any, will not impact our effective tax rate.
The following table summarizes the reconciliation of the unrecognized tax benefits activity during the years ended December 31 (in thousands):
|
|
2025 |
|
|
2024 |
|
||
Beginning unrecognized tax benefits |
|
$ |
1,314 |
|
|
$ |
1,354 |
|
Gross increases - tax positions in prior period |
|
|
1 |
|
|
|
— |
|
Gross decreases – tax positions in prior period |
|
|
— |
|
|
|
(175 |
) |
Gross increases - current year tax positions |
|
|
104 |
|
|
|
135 |
|
Purchase accounting |
|
|
— |
|
|
|
— |
|
Ending unrecognized tax benefits |
|
$ |
1,419 |
|
|
$ |
1,314 |
|
The unrecognized tax benefit amounts are reflected in the determination of the Company’s deferred tax assets. If recognized, none of these amounts would impact the company’s effective tax rate due to the existence of the valuation allowance against deferred tax assets. The Company does not foresee material changes to its uncertain tax benefits within the next twelve months.
The Company’s policy is to recognize interest and/or penalties related to income tax matters in income tax
expense. The Company has no accrual for interest or penalties on balance sheets as of December 31, 2025. The Company has no accrual for interest or penalties on balance sheets as of December 31, 2024. The Company has recognized no interest and/or penalties in the Statement of Operations for each of the years ended December 31, 2025 and 2024.
The Company is subject to taxation in the United States, various state jurisdictions, China and the United Kingdom. Due to the existence of federal, state and foreign net operating loss and credit carryovers, the Company's tax years that remain open and subject to examination by tax jurisdiction are years 2006 and forward for federal and years 2008 and forward for the state of California.
The One Big Beautiful Bill Act of 2025 (OBBBA) was signed into law on July 4, 2025. The OBBBA makes changes to the U.S. corporate income tax including reinstating the option to claim 100% accelerated depreciation deduction on qualified property and immediate expensing of domestic research and development costs while foreign expenditures will continue to be capitalized and amortized over 15 years. The enactment of the legislation did not have a material impact on our income tax rate during the year ended December 31, 2025 and is not expected to have a material impact on our income tax rate in future years.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 26, 2026 | Showing above |
| 2024 | Feb 27, 2025 | |
| 2023 | Mar 6, 2024 | |
| 2022 | Mar 20, 2023 | |
| 2021 | Mar 21, 2022 | |
| 2020 | Feb 19, 2021 | |
| 2019 | Feb 28, 2020 | |
| 2018 | Mar 15, 2019 | |
| 2017 | Mar 15, 2018 | |
| 2016 | Mar 15, 2017 | |
About Income Taxes Disclosures
The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.
Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.